AGIOS PHARMACEUTICALS, INC. (AGIO) Operating income 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) annual operating income history from SEC filings — each fiscal year as reported.
-$472.1MFY2025 · since FY2016: -$201.0M → -$472.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$472.1M | -10.9% |
| FY2024 | -$425.7M | -8.7% |
| FY2023 | -$391.5M | -0.6% |
| FY2022 | -$389.0M | -2.8% |
| FY2021 | -$378.4M | -12.7% |
| FY2020 | -$335.9M | -6.2% |
| FY2019 | -$316.3M | +12.7% |
| FY2018 | -$362.5M | -13.0% |
| FY2017 | -$320.8M | -59.6% |
| FY2016 | -$201.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AGIO financial trends
AGIO RevenueAGIO Net incomeAGIO Net marginAGIO Gross profitAGIO Gross marginAGIO Operating marginAGIO Operating cash flowAGIO Free cash flowAGIO Capital expendituresAGIO Return on equityAGIO Stock buybacksAGIO Dividends paidAGIO Total assetsAGIO Total liabilitiesAGIO Shareholders’ equityAGIO overview →